Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07773246
PHASE1/PHASE2

Phase 1/2 Study of KRRO-121 in Healthy Volunteers and Patients With UCD

Sponsor: Korro Bio, Inc.

View on ClinicalTrials.gov

Summary

Phase 1/2 Study of KRRO-121 is a randomized, placebo-controlled study in Healthy Volunteers (Phase 1 SAD and MAD) and Study Participants with Urea Cycle Disorders (Phase 2). The primary objective of the study is to evaluate the safety of KRRO-121.

Official title: A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KRRO-121 in Healthy Volunteers and Patients With Urea Cycle Disorders

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-09

Completion Date

2027-09

Last Updated

2026-08-19

Healthy Volunteers

Yes

Interventions

DRUG

KRRO-121

KRRO-121, subcutaneous injection

DRUG

Placebo

Placebo, subcutaneous injection

Locations (1)

Nucleus Network Pty Ltd

Melbourne, Victoria, Australia